SINGAPORE - Singapore-based private equity firm Quadria Capital has raised US$304 million for healthcare investments in Asia.

It announced on Tuesday that the fund will be channeled towards "high quality and scalable mid-sized healthcare companies" that can cater to the masses at affordable prices.

This includes businesses with a focus on hospital services and pharmaceuticals.

Quadria Capital's investors include asset managers, development finance institutions, institutional investors, healthcare groups and family offices from the United States, Europe, Asia and the Middle East.

The fund - the firm's third investment vehicle - has already made two investments.

One is in Medica Synergie, a hospital network in eastern India, and the other is in SOHO Global Health, one of the largest pharmaceutical manufacturing and distribution businesses in Indonesia.

"There is rising demand in Asia for quality healthcare products and services, driven by an ageing population, affluence and changing disease patterns," said Dr Amit Varma, managing partner at Quadria Capital.

"We see exciting opportunities for Quadria Capital as we position our fund to serve the needs of the region for quality healthcare and our investors for exceptional returns."

The total healthcare spend in Asia is expected to surpass US$3 trillion by 2020, higher than that of the United States and Europe combined.